• Skip to main content
  • Skip to primary sidebar

21st.BIO launches precision fermentation program for bovine alpha-lactalbumin

Asia Food Journal
  • Home
  • Latest News
  • Channels
    • Packaging
    • Processing
    • Ingredients
    • Industry
    • Automation
    • Guest Posts
    • Market Trends
  • Subscribe
  • Advertise
  • Event Calendar
  • Contact Us
    • Submit Guest Posts
Share
Leaderboard of Asia Food Journal




21st.BIO launches precision fermentation program for bovine alpha-lactalbumin

July 10, 2025 by Asia Food Journal

precision fermentation

Courtesy of 21st.BIO

Copenhagen, Denmark, and Davis, California, 10 July 2025 – 21st.BIO, a leading technology partner in precision fermentation, today announced the launch of a new development program for bovine alpha-lactalbumin (α-lac) after exclusively licensing the high-yield microbial strain from Novonesis – the global leader in biosolutions.  

From breakthrough strain to global access

Alpha-lactalbumin is a highly functional milk protein rich in essential amino acids. It is easy to digest and is linked to immune and cognitive development benefits. Bovine α-lac is currently used in infant nutrition, functional food, and health-focused applications. 21st.BIO is optimizing the Novonesis-developed strain for industrial fermentation, scale-up, and commercialization – enabling companies around the world to bring precision fermented α-lac to market, and with the ambition to be cost-competitive with its bovine counterpart.

Leaderboard of Asia Food Journal

Today, producing α-lac from bovine milk is costly and inefficient, making it one of the most expensive dairy proteins on the market. About a thousand liters of milk must be fractionated to obtain a kilogram of α-lac. 

“Alpha-lactalbumin is incredibly valuable, but current supply from cow’s milk is limited. It is challenging and costly to extract at scale, which is why current supply is mostly reserved for the very high-end infant formula market,” said Thomas Schmidt, CEO of 21st.BIO. “Through precision fermentation, we make production more efficient, sustainable, and – most importantly – available to many, not just the few. On top of this, we are able to produce α-lac of high purity, an important parameter for infant nutrition.”

Democratizing access to advanced biomanufacturing

With this program, 21st.BIO offers an animal-free, scalable, and cost-effective way to produce α-lac – using precision fermentation and a best-in-class strain from Novonesis.

“We are proud to see our world-class strain being brought to market to solve current challenges in food and nutrition by 21st.BIO,” said Thomas Batchelor, Senior Vice President of Advanced Health and Protein Solutions at Novonesis. “We continually strive to be at the forefront of innovation and this strain is one result of our pioneering work in R&D, strain development and production. We see α-lac as a great fit to 21st.BIO’s strategy and portfolio, making it the right path forward while we in Novonesis continue to focus on other protein innovation and we’re excited about the future of protein made with precision fermentation.” 

21st.BIO works with customers – from dairy, food, and beverage companies to foodtech start-ups – through a phased development program that includes:

  • Access to production-ready microbial strains
  • Tailored fermentation and downstream process development
  • Pilot and large-scale scale-up support
  • Regulatory advisory
  • Royalty-based licensing upon commercialization

“We go beyond licensing our technology to our partners,” said Thomas Schmidt. “We help them through the entire process of industrial-scale production. Our experience in functional proteins and our goal of achieving at least price parity with traditional dairy makes this a game-changer for companies looking to supply the market.”

Addressing a growing global need for dairy proteins

Global demand for dairy proteins is expected by many insiders to outpace supply by 2030, as milk production slows in many parts of the world. Feedback from industry partners points to a clear need: aging dairy farmer populations, limited scalability, and growing pressure to reduce emissions are challenging the status quo.

Thomas Schmidt explains: “We’re heading for a protein supply gap. The industry itself is telling us: We won’t be able to meet future demand using traditional methods alone. Precision fermentation is a complementary solution – one that can reduce pressure on natural resources, lower environmental impact, and create a more distributed and resilient supply chain.”

With the launch of its alpha-lactalbumin program, 21st.BIO is helping bring this unique protein – and the technology to make it – to companies around the world.

About alpha-lactalbumin (α-lac) 

Alpha-lactalbumin is a highly functional whey protein found in both cow’s milk and human milk – but in very different concentrations. In human milk, it is the dominant whey protein, representing around 20–25% of total protein content. In cow’s milk, it makes up only 3–5%, making it much more difficult and expensive to extract in large quantities.

Rich in essential amino acids like tryptophan and cysteine, α-lac is easily digestible and supports immune function, gut health, and cognitive development – especially in early life. These properties have made it a critical ingredient in high-end infant formula, including hypoallergenic and specialty formulations.

Beyond infant nutrition, α-lac is gaining interest in functional foods, ready-to-drink beverages, clinical nutrition, and dietary supplements – where high-quality, bioavailable protein is in growing demand.

However, current extraction methods from milk are highly inefficient: approximately 1,000 liters of milk are needed to produce just one kilogram of purified α-lac, making it one of the most expensive dairy proteins on the market.

Precision fermentation offers a scalable, animal-free solution. It enables consistent, high-purity α-lac production with the potential for cost competitiveness – unlocking access across industries while supporting more resilient and sustainable supply chains.

About 21st.BIO

21st.BIO was founded with one simple mission: to make leading industrial-scale precision fermentation technology accessible to as many as possible, so companies can successfully take biotech innovations to market at a competitive price. 21st.BIO focuses on developing industrial production technology for proteins and other molecules of interest for food, nutrition, agriculture, biomaterials, and biomining industries.

21st.BIO’s founders saw that too often, great bio innovation and molecules fail to translate into commercial success. The innovation is ready, the market is there, but production costs remain too high for the product to go mainstream. Industry insiders call it the ‘valley of death’, and that’s exactly what 21st.BIO intends to bridge.

Visited 2 times, 2 visit(s) today

Other Topics: 21stBIO, biotech, fermentation, Precision Fermentation, Processing

Related Articles

  • Immersive Experience Hub

    Courtesy of IFF

    IFF expands innovation center in Singapore with new immersive experience hub 
  • precision fermentation

    Courtesy of 21st.BIO

    ADM and Asahi Group sign exclusive distribution agreement for innovative postbiotic designed to support stress, mood, and sleep 
  • new ice cream creations

    Courtesy of Hydrosol

    From dairy ice cream to sorbet – fresh ideas for new ice cream creations  
  • Tetra Pak Binh Duong

    From left to right: Mr. Adolfo Orive - President and CEO, Tetra Pak Mr. Bui Minh Thanh – Vice Chairman of Ho Chi Minh City People's Committee, Mr. Thue Quist Thomasen – Chairperson of Nordic Chamber of Commerce (Nordcham), Ms. Giang Nguyen - Managing Director, Tetra Pak Vietnam, Mr. Dilip Bhave - Factory Director, Tetra Pak Binh Duong/Courtesy of Tetra Pak

    Tetra Pak Binh Duong expansion accelerates beverage carton packaging innovation to Singapore and wider Asia Pacific region
  • pharmactive saffron

    Courtesy of Pharmactive

    Saffron extract helps lighten mood
  • Meatable joins London Climate Action Week 2025

    Courtesy of Meatable

    Meatable joins London Climate Action Week 2025 with strong commitment to a sustainable future
Leaderboard of Asia Food Journal

Primary Sidebar

Stay Connected

Your browser does not support the video tag. Learn More

Trending News

  • Inspection technologyTethered caps: KHS optimizes its inspection… Tethered caps have been mandatory for all non-returnable PET bottles…
  • Euromed EcovadisRecognition for outstanding sustainability and… Euromed, a leading producer of botanical ingredients, has once again…
  • mega prime foodsMega Prime Foods turns 50 with growth plans and… Maker of country’s #1 sardines brand, Mega Sardines, sets sights…
  • greatviewGreatview operates aseptic carton packaging facility… Greatview, a leading global supplier of aseptic carton packaging solutions,…
  • Bem BrasilBem Brasil optimises storage for 500,000 tonnes of… Bem Brasil is the leading producer of pre-fried frozen chips…
  • Genu-inBrenntag Nutrition signs distribution agreement with… Distribution agreement spans Australia, Indonesia, Malaysia, the Philippines, South Korea,…
  • Restaurant Asia 2025Restaurant Asia 2025: F&B industry gathers at… Co-organised by the Restaurant Association of Singapore (RAS) and IEG…

Subsribe to Our News Letter

Subscribe To
Our Newsletter


By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

© 2025 Harvest Information. All rights reserved. Privacy Policy.

Become an F&B industry insider

Your go-to resource for all the latest trends, innovations, and news about the food and beverage industry!

 

By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

Disclaimer: Translations on this website are automated using Google Translate. While we strive for accuracy, please be cautious, as machine translations may contain errors. For critical or sensitive content, consider seeking professional human translation. We are not liable for any reliance on the translated content.